EYEG
AB Corporate Bond ETF
stockNASDAQ
InactiveSep 16, 2026
0.00USD0.000%(0.00)18
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
MA, USA
Sep 2, 2025 · $0.142
Aug 30, 2019 · 1-for-15 (reverse)
Oct 1, 2026
AB Corporate Bond ETF declares $0.1367 dividend · 
Seeking Alpha
EYEG Profile
Eyegate Pharmaceuticals Inc focuses on developing and commercializing products for treating diseases and disorders of the eye.
EYEG Performance
| Period | Price | Date | Change |
|---|